FDA Requires Stronger Warning About Risk of Neuropsychiatric Events Associated with Asthma and Allergy Medication Singulair and Generic Montelukast

A boxed warning is being added to strengthen an existing warning about the risk of neuropsychiatric events associated with the drug advising health care professionals to avoid prescribing montelukast for patients with mild symptoms, particularly those with allergic rhinitis.


US Food and Drug Administration